1.3 million Americans suffer chronically from spinal cord injuries (SCI); each year ~15,000 individuals sustain a new injury. For California, this means nearly 147,000 individuals are living with a SCI…
We aim to develop a novel stem cell treatment for spinal cord injury (SCI) that is substantially more potent than previous stem cell treatments. By combining grafts of neural stem…
Transplantation of neuronal precursors into the central nervous system offers great promise for the treatment of neurological disorders including spinal cord injury (SCI). Among the most significant consequences of SCI…
On June 9th, 2016, Jake Javier seriously injured his spinal cord in a freak accident after diving into a swimming pool just one day before he was due to graduate…
Clinical trials are risky and rely on brave pioneers who are willing to put their bodies on the line to test something never before tried in people. At its December…
Jane Lebkowski, Asterias Biotherapeutics' VP of R&D, spoke to CIRM's governing Board about the company's CIRM-funded clinical trial for spinal cord injury. Richard Lajara, the fourth participant in a previous…
In this Google Hangout, Jane Lebkowski, PhD, president of research and development at Asterias Biotherapeutics, and Kevin Whittlesey, PhD, a CIRM science officer discuss the latest progress in stem cell-based…
Katie Sharify was one of five people with spinal cord injuries to participate in the world's first clinical trial testing human embryonic stem cells. The Geron sponsored trial was supported…
Roman Reed spoke with CIRM at the World Stem Cell Summit about what he thinks patients advocates should know about stem cell research. He came to the meeting in Pasadena…
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
